FAKTOR-OPTIONSSCHEIN - IPSEN | Real-time Bid/Ask 07:38:43 2024-06-12 am EDT | ||
| 16.37 EUR / 16.48 EUR | +2.91% |
|
| Current month | +8.72% | ||
| 1 month | +12.87% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
IPSEN
| Date | Price | Change |
|---|---|---|
| 24-06-12 | 16.37 | +2.57% |
| 24-06-11 | 15.96 | +2.18% |
| 24-06-10 | 15.62 | +0.51% |
| 24-06-07 | 15.54 | -0.06% |
| 24-06-06 | 15.55 | -0.70% |
Delayed Quote Börse Stuttgart
Last update June 12, 2024 at 04:30 am EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | IPSEN |
| Issuer | Morgan Stanley |
| WKN | MG156D |
| ISIN | DE000MG156D3 |
| Date issued | 2024-03-27 |
| Strike | 90.69 € |
| Maturity | Unlimited |
| Parity | 2.07 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 16.37 € |
|---|---|
| Lowest since issue | 8.83 € |
| Spread | 0.11 € |
| Spread % | 0.67% |
Company Profile
Ipsen specialises in the research, development, manufacture and marketing of specialty medicines. Net sales by therapeutic area break down as follows:
- oncology (75.2%);
- neuroscience (21.1%);
- rare diseases (3.7%).
At the end of 2023, the group had 4 research and development centres located in France, the United Kingdom, the United States and China, and 4 manufacturing sites worldwide.
Net sales are distributed geographically as follows: Europe (40.2%), North America (33.3%) and other (26.5%).
Sector
-
Consensus: Ipsen
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
120.9
EUR
Average target price
127
EUR
Spread / Average Target
+5.07%
- Stock Market
- Certificates
- Certificat
